Meet the Start-ups

Perjan Pleunis | CEO & Co-Founder | LivingMed Biotech

Perjan Pleunis is an entrepreneurial business developer with 25 years of experience in high-tech capital sales and management within MedTech. He ventured into Biotech by co-founding LivingMed Biotech, where he’s been driving the development of a revolutionary oral vaccine platform and for which he secured €1.5M in dilutive and non-dilutive funding.

With a strong track record in high-stakes negotiations, commercial strategy execution, and challenging the status quo, he excels at transforming complex innovations into scalable business success. Now seeking new investments, he is poised to revolutionize the global fight against Avian Influenza and its far-reaching health- and economic risks.

About LivingMed Biotech

LMB wants to lead the fight against viral threads for animals and humans through scalable, game-changing vaccine solutions, securing global health and transforming food supply chains.

Our mission is to develop and commercialize the world’s first oral vaccine for avian influenza, combining breakthrough science with practical delivery methods to address a $10 billion+ market.

By simplifying disease prevention for poultry producers, reducing economic losses, and mitigating zoonotic risks, we aim to deliver unparalleled value to stakeholders and ensure a sustainable, healthier future. Together with our partners and investors, we are redefining how the world protects against the threats of infectious diseases.